Seach Medical Group Ltd (SEMG) - Net Assets
Based on the latest financial reports, Seach Medical Group Ltd (SEMG) has net assets worth ILA107.49 Million ILA (≈ $288.17K USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA148.91 Million ≈ $399.23K USD) and total liabilities (ILA41.42 Million ≈ $111.06K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of Seach Medical Group Ltd to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA107.49 Million |
| % of Total Assets | 72.18% |
| Annual Growth Rate | N/A |
| 5-Year Change | 29.89% |
| 10-Year Change | N/A |
| Growth Volatility | 35.71 |
Seach Medical Group Ltd - Net Assets Trend (2015–2024)
This chart illustrates how Seach Medical Group Ltd's net assets have evolved over time, based on quarterly financial data. Also explore SEMG asset base for the complete picture of this company's asset base.
Annual Net Assets for Seach Medical Group Ltd (2015–2024)
The table below shows the annual net assets of Seach Medical Group Ltd from 2015 to 2024. For live valuation and market cap data, see Seach Medical Group Ltd (SEMG) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ILA102.94 Million ≈ $275.97K |
+15.67% |
| 2023-12-31 | ILA88.99 Million ≈ $238.58K |
-12.42% |
| 2022-12-31 | ILA101.62 Million ≈ $272.43K |
+6.32% |
| 2021-12-31 | ILA95.58 Million ≈ $256.24K |
+20.60% |
| 2020-12-31 | ILA79.25 Million ≈ $212.47K |
+69.48% |
| 2019-12-31 | ILA46.76 Million ≈ $125.36K |
+82.02% |
| 2018-12-31 | ILA25.69 Million ≈ $68.87K |
-18.12% |
| 2017-12-31 | ILA31.38 Million ≈ $84.12K |
+962.72% |
| 2016-12-31 | ILA-3.64 Million ≈ $-9.75K |
-904.70% |
| 2015-12-31 | ILA-362.00K ≈ $-970.51 |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Seach Medical Group Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 9751300000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ILA13.01 Million | 14.23% |
| Common Stock | ILA70.65 Million | 77.28% |
| Other Comprehensive Income | ILA4.53 Million | 4.95% |
| Other Components | ILA3.23 Million | 3.54% |
| Total Equity | ILA91.42 Million | 100.00% |
Seach Medical Group Ltd Competitors by Market Cap
The table below lists competitors of Seach Medical Group Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Nexus Minerals Ltd
AU:NXM
|
$21.36 Million |
|
Welsbach Technology Metals Acquisition Corp
NASDAQ:WTMA
|
$21.36 Million |
|
Destinasi Tirta Nusantara Tbk
JK:PDES
|
$21.37 Million |
|
Everest Metals Corporation Ltd
AU:EMC
|
$21.37 Million |
|
Dynamic Metals Ltd
AU:DYM
|
$21.35 Million |
|
Inception Growth Acquisition Ltd
NASDAQ:IGTA
|
$21.35 Million |
|
Schlatter Industries AG
SW:STRN
|
$21.32 Million |
|
Nucletron Electronic Aktiengesellschaft
F:NUC
|
$21.31 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Seach Medical Group Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 77,505,000 to 91,417,000, a change of 13,912,000 (17.9%).
- Net income of 13,524,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 208,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA13.52 Million | +14.79% |
| Other Comprehensive Income | ILA-208.00K | -0.23% |
| Other Changes | ILA596.00K | +0.65% |
| Total Change | ILA- | 17.95% |
Book Value vs Market Value Analysis
This analysis compares Seach Medical Group Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 89.65x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | ILA-302.04 | ILA240.80 | x |
| 2016-12-31 | ILA-36.37 | ILA240.80 | x |
| 2017-12-31 | ILA1.10 | ILA240.80 | x |
| 2018-12-31 | ILA0.95 | ILA240.80 | x |
| 2019-12-31 | ILA1.77 | ILA240.80 | x |
| 2020-12-31 | ILA2.43 | ILA240.80 | x |
| 2021-12-31 | ILA2.55 | ILA240.80 | x |
| 2022-12-31 | ILA2.53 | ILA240.80 | x |
| 2023-12-31 | ILA2.28 | ILA240.80 | x |
| 2024-12-31 | ILA2.69 | ILA240.80 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Seach Medical Group Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.79%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.88%
- • Asset Turnover: 1.17x
- • Equity Multiplier: 1.61x
- Recent ROE (14.79%) is above the historical average (1.90%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 0.00% | -267.27% | 0.66x | 0.00x | ILA-5.32 Million |
| 2016 | 0.00% | 17.61% | 4.11x | 0.00x | ILA1.94 Million |
| 2017 | 11.72% | 24.04% | 0.34x | 1.42x | ILA433.80K |
| 2018 | 36.90% | 43.21% | 0.55x | 1.54x | ILA5.84 Million |
| 2019 | -48.23% | -78.22% | 0.43x | 1.44x | ILA-27.23 Million |
| 2020 | 15.10% | 32.52% | 0.40x | 1.17x | ILA4.04 Million |
| 2021 | 6.22% | 7.94% | 0.52x | 1.49x | ILA-3.25 Million |
| 2022 | -3.96% | -2.54% | 0.83x | 1.88x | ILA-12.03 Million |
| 2023 | -13.56% | -6.99% | 1.15x | 1.69x | ILA-18.26 Million |
| 2024 | 14.79% | 7.88% | 1.17x | 1.61x | ILA4.38 Million |
Industry Comparison
This section compares Seach Medical Group Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $576,378,255
- Average return on equity (ROE) among peers: 21.33%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Seach Medical Group Ltd (SEMG) | ILA107.49 Million | 0.00% | 0.39x | $21.35 Million |
| Canzon Israel Ltd (CNZN) | $4.23 Million | -112.18% | 0.24x | $1.81 Million |
| Intercure (INCR) | $397.67 Million | -17.05% | 0.92x | $38.85 Million |
| Intelicanna Ltd (INTL) | $4.41 Billion | 12.46% | 8.24x | $10.11 Million |
| Kamada (KMDA) | $28.39 Million | 0.92% | 2.14x | $375.32 Million |
| Nextage Therapeutics Ltd (NXTG) | $3.66 Million | -57.11% | 0.64x | $5.79 Million |
| Rekah Pharmaceutical Industry Ltd (REKA) | $144.62 Million | -15.54% | 1.04x | $33.75 Million |
| Teva Pharmaceutical Industries Ltd (TEVA) | $49.90 Million | 15.23% | 1.79x | $1.09 Billion |
| Together Startup Network Ltd (TGTR) | $549.00K | 387.98% | 0.54x | $9.92 Million |
| Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) | $143.82 Million | -22.70% | 0.32x | $28.21 Million |
About Seach Medical Group Ltd
Seach Medical Group Ltd manufactures and sells medicinal cannabis products worldwide. The company offers cannabis oil and medical cannabis inflorescence products. Seach Medical Group Ltd was founded in 2002 and is based in Ramat Gan, Israel.